Cytokine Market Accelerates with Immuno-Oncology Pipeline & U.S.-Japan R&D Alliances | CytoAgents, Cullinan Oncology, Inc, Genentech, Inc, AbbVie Inc

Global Cytokine Market reached US$ 72.3 billion in 2022 and is expected to reach US$ 132.2 billion by 2030, growing with a CAGR of 7.6 % during the forecast period 2023-2030.

Cytokine Market Report by DataM Intelligence offers a detailed assessment of the global immunology and biologics landscape, highlighting market size, key players, and critical growth drivers. With a focus on cytokine-modulating biologics, diagnostics for hyperinflammation, and repurposed small-molecule inhibitors, the report delivers strategic insights for stakeholders from 2025 to 2033.

In 2025, high-impact reviews and translational initiatives from U.S. centers (and dedicated cytokine research consortia) renewed focus on biomarkers and targeted therapies for cytokine storm syndromes, accelerating investment into precision diagnostics and repurposing trials.

Download exclusive insights with our detailed sample report (Corporate Email ID gets priority access): https://www.datamintelligence.com/download-sample/cytokine-market?ophp

Cytokine Market Competitors Overview:

CytoAgents, Cullinan Oncology, Inc, Genentech, Inc, AbbVie Inc, Sanofi, Novartis AG, Pfizer Inc, F. Hoffmann-La Roche Ltd , Merck KGaA, GenScript and among others.

Important Industry Updates:

On March 27, 2023, The U.S. Food and Drug Administration (FDA) has approved CLN-617, a fusion protein composed of two potent and synergistic antitumor cytokines, IL-2 and IL-12, with a collagen binding domain intended for retention in the tumour microenvironment (TME) after intratumoral injection, according to Cullinan Oncology, Inc., a biopharmaceutical company focused on modality-agnostic targeted oncology therapies. In a Phase 1 trial, Cullinan Oncology will initially assess CLN-617 in patients with advanced solid tumours.

On June 15, 2023, Genentech, a member of the Roche Group, announced that the FDA had approved Columvi (glofitamab-gxbm) for the treatment of adult patients with relapsed or refractory (R/R) diffuse large B-cell lymphoma (DLBCL) that is not otherwise specified or large B-cell lymphoma (LBCL) arising from follicular lymphoma, following two or more lines of systemic therapy.

On May 19, 2023, The FDA has approved EPKINLYTM (epcoritamab-bysp), the first and only T-cell engaging bispecific antibody, for the treatment of adult patients with diffuse large B-cell lymphoma (DLBCL), not otherwise specified (NOS), including DLBCL resulting from indolent lymphoma, and high-grade B-cell lymphoma (HGBL), following two or more lines of systemic therapies.

Methodology and Scope

The Cytokine Market Report is built on a rigorous research methodology that integrates primary interviews, expert insights, and validated secondary data from company reports, industry publications, and reliable databases. Utilizing both bottom-up and top-down approaches, the analysis ensures high data accuracy through triangulation. The report covers current market dynamics, growth opportunities, and key strategic developments across global and regional markets.

Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/cytokine-market?ophp

Cytokine Market Segments Overview:

∎ By Type

Chemokines
Interferons
Interleukins
Tumor necrosis factor (TNF)
Monokines
Lymphokines
Colony-stimulating factors (CSF)

∎ By Application

Cancer
Orthopedic
Dermatology
Others

∎ By End Users

Pharmaceutical & Biotechnology Companies
Contract Research Organizations
Research Institutes
Others

Regional Overview for Cytokine Market:

⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Looking for in-depth insights? Grab the full report: https://www.datamintelligence.com/buy-now-page?report=cytokine-market

The Report Covers:

➡ In-depth analysis of the demand-supply gap, market size estimates, SWOT and PESTEL analysis, along with global market forecasts.
➡ Strategic recommendations with a focused go-to-market approach.
➡ An unbiased evaluation of overall market performance.
➡ Region- and country-specific insights, with customized reports available upon request.
➡ Identification of high-potential and niche segments and regions demonstrating strong growth prospects.

People Also Ask:

➤ What are the current global trends in sales, production, imports, and exports within the Cytokine market?
➤ Who are the leading manufacturers, and what are their production volumes, pricing strategies, and revenue metrics?
➤ What are the major opportunities and challenges facing vendors in this market?
➤ Which product categories, applications, or end-user segments are contributing most to market growth and share?
➤ What are the primary factors driving and restraining growth in the Cytokine market?

Unlock 360° Market Intelligence with 2 Days FREE Trial Access of DataM Subscription Now!: https://www.datamintelligence.com/reports-subscription?ophp

✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Pipeline Analysis For Drugs Discovery
✅ Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Competitive Landscape

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.